Literature DB >> 28771010

Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis.

Jinghui Wang, Yan Li, Yinfeng Yang, Jian Du, Miaoqing Zhao, Feng Lin, Shuwei Zhang, Bin Wang1.   

Abstract

As a chronic inflammatory and angiogenic disease with increased morbidity and mortality, rheumatoid arthritis (RA) is characterized by the proliferation of synovial tissue and the accumulation of excessive mononuclear infiltration, which always results in the joint deformity, disability, and eventually the destruction of the bone and cartilage. Traditional Chinese Medicine (TCM), with rich history of proper effectiveness in treating the inflammatory joint disease containing RA, has long combated such illness from, actually, an integrative and holistic point of view. However, its "multi-components" and "multi-targets" features make it very difficult to decipher the molecular mechanisms of RA from a systematic perspective if employing only routine methods. Presently, an innovative systems-pharmacology approach was introduced, which combined the ADME screening model, drug targeting, and network pharmacology, to explore the action mechanisms of botanic herbs for the treatment of RA. As a result, we uncovered 117 active compounds and 85 key molecular targets from seven RA-related herbs, which are mainly implicated in four signaling pathways, that is, vascular endothelial growth factor, PI3K-Akt, Toll-like receptor, and T-cell-receptor pathways. Additionally, the network relationships among the active components, target proteins, and pathways were further built to uncover the pharmacological characters of these herbs. Besides, molecular dynamics (MD) simulations and molecular mechanics-Poisson-Boltzmann surface area calculations were carried out to explore the binding interactions between the compounds and their receptors as well as to investigate the binding affinity of the ligand to their protein targets. In vitro experiments by ligand binding assays validate the reliability of the drug-target interactions as well as the MD results. The high binding affinities and good inhibitions of the active compounds indicate that the potential therapeutic effects of these herbal medicines for treating RA are exerted probably through the modulation of these relevant proteins, which further validates the rationality and reliability of the drug-target interactions as well as our the network-based analytical methods. This work may be of help for not only understanding the action mechanisms of TCM and for discovering new drugs from plants for the treatment of RA, but also providing a novel potential method for modern medicine in treating complex diseases.

Entities:  

Keywords:  MD; MM-PBSA; Rheumatoid arthritis; Systems-Pharmacology; TCM

Mesh:

Substances:

Year:  2017        PMID: 28771010     DOI: 10.1021/acs.molpharmaceut.7b00505

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

Review 1.  Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective.

Authors:  Ting-Ting Luo; Yuan Lu; Shi-Kai Yan; Xue Xiao; Xiang-Lu Rong; Jiao Guo
Journal:  Chin J Integr Med       Date:  2019-04-02       Impact factor: 1.978

2.  Anti-inflammatory and anti-angiogenic activities in vitro of eight diterpenes from Daphne genkwa based on hierarchical cluster and principal component analysis.

Authors:  Ling Wang; Xin-Yi Lan; Jun Ji; Chun-Feng Zhang; Fei Li; Chong-Zhi Wang; Chun-Su Yuan
Journal:  J Nat Med       Date:  2018-04-21       Impact factor: 2.343

3.  Combining an in silico approach with an animal experiment to investigate the protective effect of troxerutin for treating acute lung injury.

Authors:  Ying Li; Pan Ma; Jin Fu; Jingjing Wu; Xue Wu
Journal:  BMC Complement Altern Med       Date:  2019-06-10       Impact factor: 3.659

4.  A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases.

Authors:  Chun Li; Xia Du; Yang Liu; Qi-Qi Liu; Wen Bing Zhi; Chun Liu Wang; Jie Zhou; Ye Li; Hong Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-08       Impact factor: 2.629

5.  Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Yongkang Wang; Yinfeng Yang; Honglei Gao; Ting Ouyang; Luyao Zhang; Jili Hu; Sheng Hu; Hongxing Kan
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

6.  Hansenia weberbaueriana (Fedde ex H.Wolff) Pimenov & Kljuykov Extract Suppresses Proliferation of HepG2 Cells via the PTEN-PI3K-AKT Pathway Uncovered by Integrating Network Pharmacology and Iin Vitro Experiments.

Authors:  Yueqin Feng; Fengjin Hao
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.810

7.  Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach.

Authors:  Tian Xu; Chongyang Ma; Shuning Fan; Nan Deng; Yajun Lian; Ling Tan; Weizhe Du; Shuang Zhang; Shuling Liu; Beida Ren; Zhenhan Li; Qingguo Wang; Xueqian Wang; Fafeng Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-17       Impact factor: 2.629

8.  Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Atractylodes macrocephala Koidz. for the Treatment of Chronic Gastritis.

Authors:  Songhong Yang; Jinlian Zhang; Yiqi Yan; Ming Yang; Chao Li; Junmao Li; Lingyun Zhong; Qianfeng Gong; Huan Yu
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

9.  Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis.

Authors:  Haojie Yang; Ying Li; Sichen Shen; Dan Gan; Changpeng Han; Jiong Wu; Zhenyi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-20       Impact factor: 2.629

Review 10.  Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview.

Authors:  Vijayakumar Shrihastini; Pandiyan Muthuramalingam; Sivakumar Adarshan; Mariappan Sujitha; Jen-Tsung Chen; Hyunsuk Shin; Manikandan Ramesh
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.